Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients

Saved in:
Bibliographic Details
Published inCancer cell Vol. 40; no. 4; pp. 335 - 337
Main Authors Canti, Lorenzo, Ariën, Kevin K., Desombere, Isabelle, Humblet-Baron, Stéphanie, Pannus, Pieter, Heyndrickx, Leo, Henry, Aurélie, Servais, Sophie, Willems, Evelyne, Ehx, Grégory, Goriely, Stanislas, Seidel, Laurence, Michiels, Johan, Willems, Betty, Goossens, Maria E., Beguin, Yves, Marchant, Arnaud, Baron, Frédéric
Format Journal Article Web Resource
LanguageEnglish
Published United States Elsevier Inc 11.04.2022
Cell Press
Subjects
Antibody Formation
BNT162 Vaccine
COVID-19 - prevention & control
Hematology
Human health sciences
Humans
Hématologie
Immunologie & maladie infectieuse
Immunology & infectious disease
Letter
SARS-CoV-2
Sciences de la santé humaine
Vaccination
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
scopus-id:2-s2.0-85125497316
These authors contributed equally
ISSN:1535-6108
1878-3686
1878-3686
DOI:10.1016/j.ccell.2022.02.005